Since the first detection of highly pathogenic avian influenza H5N1 in U.S. dairy cattle in early 2024, the virus has spread rapidly, posing a major public health concern as the number of human cases continues to rise.

This study demonstrates that the traditional Grana-type cheese production process effectively inactivates both LPAIV and HPAIV, even at high contamination levels.

It is necessary to increase knowledge about the safety and effectiveness of influenza vaccination during pregnancy to improve awareness among patients and healthcare professionals and increase to increase vaccination coverage.

Annual vaccination with LAIV4 or IIV4 remains the best way to protect children against influenza infection.

The avian influenza virus is a pathogen that has been well known to the scientific community ever since its first detection in 1996.

Recent scientific advancements enabled the accelerated development, production, and evaluation of COVID-19 vaccines, leveraging novel technologies that are estimated to have prevented approximately 1.6 million hospitalizations and 235.000 deaths in the US

In this 3-part podcast series, the International Federation on Ageing (IFA) aims to raise awareness of hMPV. The series will feature scientists, clinicians and the voices of older people and groups representing those most at risk of serious disease.

Seasonal influenza activity is low. Nationally, during Week 23, the percentage of respiratory specimens testing positive for influenza virus in clinical laboratories was 1.7%.

The recent emergence of highly pathogenic H5N1 avian influenza virus infections in dairy cows and humans in the U.S. has raised alarms regarding the potential for a pandemic.

The technology provides a universal solution to respiratory viruses, regardless of an individual's immune history – for example, people who do not sufficiently respond to a vaccine, or don't get vaccinated

Swine influenza viruses are found throughout the year on Dutch pig farms. Viruses descending from the 2009 influenza pandemic outbreak spread repeatedly from humans to pigs afterwards.

H5N1 clade 2.3.4.4b has spread globally since 2021, decimating avian species, and has spilled over into mammalian species, causing sporadic infections and fatal outbreaks in sea lions, cats, mink and dairy cattle.

The European Commission's Health Emergency Preparedness & Response Authority brought together industry stakeholders, innovators and policymakers in Brussels to advance medical countermeasure and innovation, and enhance collaboration in health preparedness

This group will lead the development of a Call to Action to advocate for better access to treatments, in particular COVID- 19.

The initiative consist of key actions, that will amongst others, speed-up vaccine development to less than four months from identifying a pathogen's genomic sequence.

What is the risk of acute cardiovascular complications in adults hospitalized for respiratory syncytial virus (RSV) vs influenza or SARS-CoV-2 Omicron infection?

Agreement’s adoption follows three years of intensive negotiation launched due to gaps and inequities identified in national and global COVID-19 response.

Due to its climatic variability, complex mobility networks and geographic expanse, the United States represents a compelling setting to explore the transmission processes that lead to heterogeneous yearly seasonal influenza epidemics.

Celebrated the XIX European Patients’ Rights Day at the EU Parliament

Human infections with swIAV have been detected sporadically in Europe whereas in the United States, such infections have been detected more frequently.

Several viruses that cause problems for human beings originated in bats. However, cellular and tissue models for understanding virus infection in these important reservoir species are limited.

Mandatory housing measures introduced across a large swathe of England to try and curb the spread of avian influenza are being lifted from today (15 May).

The 2025 edition provides the most comprehensive and up-to-date analysis of the nursing workforce.

Several mucosal vaccines are in development, and consistent methodologies assessing mucosal IgA are crucial for evaluation across clinical trials.